Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
In the debate over the high cost of prescription drugs, pharmacy benefit managers are hotly contested. PBMs, the middlemen in ...
The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...
Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...
The Federal Trade Commission (FTC) released its second interim staff report “Specialty Generic Drugs a Growing Profit Center ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback